Temporomandibular joint dysfunction

Atlanta, Georgia's, 19th Street Dental is Recognized as a 2024 Top Patient Rated Dentist

Retrieved on: 
Thursday, March 21, 2024
Boston University, TMJ, Dental care, Align Technology, Environment, Education, Patient, Orthodontics, Temporomandibular joint dysfunction, University, Dental, Multimedia, Dentist, Goldman School, Dentistry

ATLANTA, March 21, 2024 /PRNewswire-PRWeb/ -- Conveniently located at 232 19th St NW, Ste 7200 in Atlanta, GA, 19th Street Dental is a well-respected dental practice known for its commitment to providing state-of-the-art dentistry with a personal touch. The team has been named a 2024 Top Patient Rated Dentist by Find Local Doctors, a reputable online directory that recognizes outstanding medical providers and dentists based on superior reviews and ratings from patients. At 19th Street Dental, patients can expect modern dentistry delivered with a personal touch.

Key Points: 
  • At 19th Street Dental , patients can expect modern dentistry delivered with a personal touch.
  • From cosmetic dentistry to orthodontics to emergency dental care , 19th Street Dental is a one-stop shop for all dental needs.
  • From sedation options for anxious patients to convenient scheduling with early morning appointments available, 19th Street Dental strives to make dental care accessible and stress-free.
  • More about 19th Street Dental:
    Dr. Trushar Patel earned his Doctorate of Dental Medicine at Boston University's Goldman School of Dental Medicine.

Cosmetic, Restorative, and Prosthodontic Specialists at Metropolitan Dental Care in Manhattan Launch New Website

Retrieved on: 
Thursday, December 21, 2023
Dentistry, Prosthodontics, Dental implant, Obstructive sleep apnea, New Yorker, Dentist, Health, Private practice, Dentures, American Academy, Patient, Temporomandibular joint dysfunction, Cosmetic dentistry

NEW YORK, Dec. 21, 2023 /PRNewswire-PRWeb/ -- Dr. Nicole Mermet, an accredited member of the American Academy of Cosmetic Dentistry and the American Academy of Facial Cosmetics, is proud to announce that Metropolitan Dental Care has recently launched a new website at https://www.metropolitandentalcarenyc.com.

Key Points: 
  • Metropolitan Dental Care, an award-winning holistic dental practice specializing in cosmetic dentistry, restorative dental treatments (including prosthodontics), and TMJ and sleep apnea treatment, has launched a new website at https://www.metropolitandentalcarenyc.com .
  • Metropolitan Dental Care also provides a full suite of cosmetic dental procedures.
  • According to Dr. Mermet, who has been in private practice in New York City since 2002, the new website better reflects the specializations available at Metropolitan Dental Care.
  • The modern office of Metropolitan Dental Care is equipped with all of the latest advancements in dental technology that enhance patient outcomes, comfort, and experience.

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON'S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

Retrieved on: 
Thursday, October 26, 2023
Temporomandibular joint, Mouth, Physician, Head, Osteoarthritis, Pathology, Temporomandibular joint dysfunction, Publication, Umbilical cord, Injection, Massage, Research, PRF, Wharton's jelly, Reynolds, Subluxation, Medicine, NP, Patient, Muscular system, TMD, Today, Dentistry, Medical imaging, Nursing, Veterinary medicine, Jelly, Pain, TMJ, Regenerative medicine

PENSACOLA, Fla., Oct. 26, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects. The case study titled "Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Study," was published by Walsh Medical Media and can be accessed in its entirety here.

Key Points: 
  • PENSACOLA, Fla., Oct. 26, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.
  • The case study titled "Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Study," was published by Walsh Medical Media and can be accessed in its entirety here.
  • After one application of Regenative's Wharton's Jelly allograft, the patient's pain improved by an average of 75% after 90 days.
  • "A few years ago, we started using PRF (platelet-rich fibrin) therapy in the jaw joint, and we thought that was revolutionary.

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, ANNOUNCE NEW CARE ADVANCEMENTS USING WHARTON'S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

Retrieved on: 
Tuesday, October 3, 2023
Injection, TMD, Muscular system, Umbilical cord, Physician, Pathology, Head, Osteoarthritis, Research, Medicine, Reynolds, Today, Massage, Temporomandibular joint, PRF, Publication, Patient, Temporomandibular joint dysfunction, Wharton's jelly, NP, Subluxation, Mouth, Dentistry, Medical imaging, Nursing, Veterinary medicine, Regenerative medicine, Jelly, TMJ, Pain

PENSACOLA, Fla., Oct. 3, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective case series demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.

Key Points: 
  • PENSACOLA, Fla., Oct. 3, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective case series demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.
  • Standard treatment includes simply resting the jaw muscles and avoiding use, massage, physical therapy, medication management, and, when all else fails, surgery.
  • After one application of Regenative's Wharton's Jelly allograft, the patient's pain improved by an average of 75% after 90 days.
  • "A few years ago, we started using PRF (platelet-rich fibrin) therapy in the jaw joint, and we thought that was revolutionary.

The Inner Circle Acknowledges, Bradley Hester as a Top Pinnacle Professional for his contributions to the Dentistry Field

Retrieved on: 
Wednesday, July 5, 2023
Dentistry, Bachelor of Science in Nursing, University, Oral medicine, Most valuable player, IV, Education, Volunteers in Medicine, Anxiety, University of Portland, Fear, Oregon Health & Science University, Temporomandibular joint dysfunction, Sleep apnea, Private practice, Volunteering, Multimedia, TMJ, Inner circle, High, Oregon Health & Science University School of Dentistry, International Congress of Oral Implantologists, Patient, Aesthetics, Dog, Dental, Diagnosis, Mouth, Nursing, Science, Central Oregon, Medicine

BEND, Ore., July 5, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Bradley Hester is acknowledged as a Top Pinnacle Professional for his contributions to the Dentistry Field.

Key Points: 
  • BEND, Ore., July 5, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Bradley Hester is acknowledged as a Top Pinnacle Professional for his contributions to the Dentistry Field.
  • Dr. Hester was called to the field of dentistry when he was in 7th grade and began his educational journey at the University of Portland.
  • He earned a Bachelor of Science degree; won a scholarship to play baseball; and was voted Most Valuable Player.
  • A highlight of his higher education experience, the doctor also achieved the Highest Batting Average award during his senior season.

Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update

Retrieved on: 
Thursday, June 8, 2023
AFD, Temporomandibular joint dysfunction, SEC filing, Migraine, TMD, DME, Marketing, Patent Cooperation Treaty, DSO, OSA, Sale, Organization, Net, Dentist, Vivos, Traction, Dental Service Organizations, Patent, Patient, Acquisition, Webcast, Security (finance), FDA, Durable medical equipment, Therapy, Very important person, VIP, Pharmaceutical industry, Cryptocurrency, Bruxism

LITTLETON, Colo., June 08, 2023 (GLOBE NEWSWIRE) --  Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep issues arising from certain dentofacial abnormalities, today reported financial results and operating highlights for the first quarter ended March 31, 2023.

Key Points: 
  • As of March 31 2023, patients treated with The Vivos Method totaled over 35,000, compared to approximately 28,000 as of the first quarter of 2022.
  • The study demonstrated statistically significant results, with ninety-two percent (92%) of study patients reporting their migraine symptoms were completely resolved following completion of treatment.
  • “Vivos is evolving into a more scalable and sustainable growth company with a clear path to cash flow positive operations.
  • A live webcast of the conference call can be accessed on Vivos’ website at https://vivos.com/investor-relations .

Clinical Study Shows 92% of Patients Report Resolution of Migraine Headaches Using Vivos’ POD® Appliance Treatment

Retrieved on: 
Monday, May 1, 2023
MIDAS, Temporomandibular joint dysfunction, Federal Food, Drug, and Cosmetic Act, Migraine, Headache, TMD, Depression, Neck pain, Ear, Dentist, Anxiety, Sleep, Bruxism, Jaw, Pain, Dizziness, Patient, FDA, Therapy, Pharmaceutical industry, Dentistry, Vivos

The study demonstrated statistically significant results, with ninety-two percent (92%) of study patients reporting their migraine symptoms were completely resolved following completion of treatment.

Key Points: 
  • The study demonstrated statistically significant results, with ninety-two percent (92%) of study patients reporting their migraine symptoms were completely resolved following completion of treatment.
  • Prior to treatment patients had an average MIDAS score of 23.96 +/- 21.34 and following treatment had a MIDAS score of 2.58 +/- 4.87, a reduction of 89.2%.
  • Migraine headaches affect over 39 million people in the United States alone according to the American Migraine Foundation.
  • Dentists who are using this technology report migraine resolution in about 9 out of 10 migraine sufferers.

Vivos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Operational Update

Retrieved on: 
Thursday, March 30, 2023
Nexus, AFD, Insurance, Temporomandibular joint dysfunction, DNA, Intellectual property, ASC, SEC filing, International, TMD, DME, Classification, COVID-19, Patent Cooperation Treaty, DSO, OSA, Sale, Snoring, Pain, Organization, Dentist, Acquisition, Dental Service Organizations, Patent, Patient, Annual report, Webcast, Growth, Security (finance), FDA, Durable medical equipment, Regulation of tobacco by the U.S. Food and Drug Administration, Therapy, Sleep, Food, VIP, Pharmaceutical industry, Cryptocurrency, Video game, Vivos, Bruxism

LITTLETON, Colo., March 30, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a medical device and technology company that delivers training and a full line of highly effective proprietary oral appliances for the treatment of breathing related sleep disorders in adults, including mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today reported financial results and operating highlights for the fourth quarter and full year ended December 31, 2022.

Key Points: 
  • As of December 31 2022, patients treated with The Vivos Method totaled over 33,000, compared to approximately 25,000 as of the end of 2021.
  • The full 10-K report will be available on the SEC Filings section of the Investor Relations section of Vivos’ website at https://vivos.com/investor-relations .
  • A live webcast of the conference call can be accessed on Vivos’ website at https://vivos.com/investor-relations .
  • An online archive of the webcast will be available on the Company’s website for 30 days following the call.

Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from Advanced Facialdontics, LLC

Retrieved on: 
Wednesday, March 1, 2023
Dentist, Night, Therapy, OSA, Snoring, Sleep, Neck pain, Headache, Pain, AFD, Acquisition, DDS, CARE, Chronic pain, Tooth loss, FDA, Patient, Security (finance), Inflammation, TMD, PCT, Intellectual property, Fatigue, International, Andrew Clench, Temporomandibular joint dysfunction, Pharmaceutical industry, Dentistry, Research, Bruxism, Vivos, TMJ

With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product portfolio and revenue potential.

Key Points: 
  • With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product portfolio and revenue potential.
  • Studies have shown that there is a clear connection between OSA and TMD.
  • Kirk Huntsman, Vivos’ Chairman and Chief Executive Officer, commented “This acquisition adds important technology and products that immediately open up new markets to us with significant revenue potential.
  • Dr. Simonetti said, “I am elated to join the Vivos team with our company’s novel line of products and technology.

Athletico Physical Therapy Opens in Cincinnati, Ohio

Retrieved on: 
Wednesday, February 8, 2023
Insurance, TMD, Dizziness, Jaw, DPT, ATC, Injury, Patient, Diagnosis, Pain, Clinic, PT, Therapy, Health, Risk, Burger King, Temporomandibular joint dysfunction, Athletico Physical Therapy, Communication, Peter Hancock (professor), Headache, Nursing, Dentistry, Health insurance, Atlético

CINCINNATI, Feb. 8, 2023 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Cincinnati, Ohio, located in the Delhi Shopping Center near Burger King. This location offers convenient hours, including early morning, late evening and Saturday appointments, and does not require a referral or prescription to start treatment. To learn more, or to schedule a free assessment, visit www.athletico.com/CincinnatiDelhi.

Key Points: 
  • CINCINNATI, Feb. 8, 2023 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Cincinnati, Ohio, located in the Delhi Shopping Center near Burger King.
  • "My passion for helping others recover from injuries started after sustaining injuries throughout my sports career and experiencing physical therapy firsthand.
  • As a physical therapist, I'm able to support patients throughout recovery to help them achieve their individual goals," said Brandon Polking, PT, DPT, ATC and Clinic Manager of Athletico Cincinnati – Delhi.
  • If you experience dizziness or other balance issues, take our Vestibular Quiz to find out if your symptoms can be treated with physical therapy.